RxDoctor Payments Data

Mark Hawkins, MD

Family Medicine · Claremont, NCNPI 1023157229

Payments from drug & device makers

$406in general payments, 2019–2025

Across 25 payments — averaging $16.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$86
  • Pfizer$75
  • AstraZeneca$68
  • Lilly USA, LLC$35
  • Phathom Pharmaceuticals, Inc.$31
  • Amgen$31
  • plus $80 from 4 others

What the payments were for

  • Food & beverage$406100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$406 in reported general payments places this provider in the 55th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$80,724
Medicare patients
117
Services billed
1,219

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide72$72,077
TrulicityDulaglutide59$66,938
MounjaroTirzepatide43$55,017
EliquisApixaban48$40,144
ProliaDenosumab23$39,269
JardianceEmpagliflozin33$37,159
JanuviaSitagliptin Phosphate17$17,969
BelsomraSuvorexant23$16,490
XareltoRivaroxaban19$14,630
KerendiaFinerenone13$9,977
FarxigaDapagliflozin Propanediol11$6,326
Combivent RespimatIpratropium/Albuterol Sulfate12$5,588
Lantus SolostarInsulin Glargine,hum.Rec.Anlog23$3,232
Atorvastatin Calcium236$2,973
Rosuvastatin Calcium205$2,526

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$35$121,955102 claims
Novo NordiskOzempic$86$72,07772 claims
PfizerEliquis$75$40,14448 claims
AmgenProlia$31$39,26923 claims
AstraZenecaFarxiga$68$6,32611 claims
AbbVieSynthroid$15$84514 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Claremont

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →